Clinical utility of cytomegalovirus urine cultures for ophthalmic care in patients with HIV

British Journal of Ophthalmology

Volumn 80, Issue 9, 1996, Pages 818-822

  Gellrich, Marcus M ^a,b   Baumert, Elisabeth ^a   Rump, Jörg A ^a   Vaith, Peter ^a   Hufert, Frank T ^a   Hansen, Lutz L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN;

ARTICLE; CYTOMEGALOVIRUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROPHYLAXIS; RETINITIS; RISK; SCREENING; URINE CULTURE;

EID: 0029969730     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.9.818     Document Type: Article

References (25)

1. Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology 1983;90:859-73.
2. Salmon D, Lacassin F, Harzic M, Leport C, Perronne C, Bricaire F, et al. Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. J Med Virol 1990;32:160-3.
3. Fabricius E-M. Augenmanifestationen bei HIV-Infektionen. Stuttgart:Enke, 1992.
4. Garweg J. Opportunistische Augenerkrankungen im Rahmen der HIV-Infektion. Klin Monatsbl Augenheilkd 1993; 202:465-70.
5. Dhillon B. The management of cytomegalovirus retinitis in AIDS. Br J Ophthalmol 1994;78:66-9.
6. Zurlo JJ, O'Neill D, Polis MA, Manischewitz J, Yarchoan R, Baseler M, et al. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med 1993;118:12-7.
7. Freymuth F, Gennetay E, Petitjean J, Eugene G, De Ligny BH, Ryckelynck JP, et al. Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection. J Clin Microbiol 1994;32:1614-8.
8. Fauci AS. The human immunodeficiency virus. Infectivity and mechanisms of pathogenesis. Science 1988;239:617-22.
9. US Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. J Acquir Immun Defic Syndr 1993;6:46-55.
10. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994;120:932-44.
11. Kuppermann BD, Petty JG, Richman DD, Mathews WC, Fullerton SC, Rickman LS, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-82.
12. McCarthy M. Oral ganciclovir fails to prevent CMV in HIV trial. Lancet 1995;346:895.
13. Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Ann Intern Med 1986;105:234-7.
14. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985;21:217-21.
15. The Oral Ganciclovir European and Australian Cooperative Study Group. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinits recurrence in patients with AIDS. AIDS 1995;9:471-7.
16. Palestine AG, Rodrigues MM, Macher AM, Chan CC, Lane HC, Fauci AS. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology 1984;91: 1092-9.
17. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4+ lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991;4: 770-6.
18. Drew WL, Mills J, Levy J, Dylewski J, Casavant C, Ammann AJ, et al. Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann Intern Med 1985;103:61-6.
19. Gerna G, Parea M, Percivalle E, Zipeto D, Silini E, Barbarini G, et al. Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS 1990;4:1027-31.
20. Drew WL, Mintz L, Miner RC, Sands M, Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis 1981;143:188-92.
21. Cheong I, Flegg PJ, Brettle RP, Welsby PD, Burns SM, Dhillon B, et al. CMV disease in AIDS: the Edinburgh experience. Int J STD and AIDS 1992;3:324-8.
22. Peters BS, Beck EJ, Anderson S, Coleman D, Coker R, Main J, et al. Cytomegalovirus infection in AIDS. Pattern of disease, response to therapy and trends in survival. J Infect 1991;23:123-8.
23. Geier St A, Gürtler L, Klauss V, Mueller A, Bader L, Eberle J, et al. Unterschied in der Nachweisbarkeit von Humanem Immunschwäche Virus Typ 1 in Tränenflüssigkeit und Blutlymphozyten. Klin Monatsbl Augenheilkd 1992;201: 164-8.
24. Erice A, Holm MA, Gill PC, Henry S, Dirksen CL, Dunn DL, et al. Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol 1992;30:2822-5.
25. Revello MG, Percivalle E, Sarasini A, Baldanti F, Furione M, Gerna G. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J Infect Dis 1994;170:1275-9.